Central Miami Medical Institute is a clinical research site located in Miami, Florida, United States 33125.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Central Miami Medical Institute has participated in 10 clinical trials with 4 currently active.
Therapeutic areas: Obsessive Compulsive Disorder, Early Alzheimer´s Disease, Obsessive-Compulsive Disorder.
Sponsors: Biohaven Pharmaceuticals, Inc., Novo Nordisk A/S, Xenon Pharmaceuticals Inc..
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Central Miami Medical Institute has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Miami Medical Institute has 10 clinical trials on record, with 4 currently active. Their work covers Obsessive Compulsive Disorder, Early Alzheimer´s Disease, Obsessive-Compulsive Disorder.
Yes — Central Miami Medical Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.